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Abstract
Background: To test whether a site-specific hysteroscopic biopsy-induced injury in the endometrium during the
controlled ovarian hyperstimulation cycle improves subsequent embryo implantation in patients with repeated
implantation failure, a total of 30 patients who have had good responses to controlled ovulation stimulation but
have failed to achieve pregnancy after two or more transfers of good-quality embryos were recruited in this
prospective study.
Methods: A single, site-specific hysteroscopic biopsy-induced injury was generated on the posterior endometrium
at midline 10-15 mm from the fundus during the D4-D7 period of the ongoing controlled ovarian hyperstimulation
cycle in six patients.
Results: Patients received endometrial biopsy protocol achieved a pregnancy rate of 100%. By contrast, only 46%
of patients with similar clinical characteristics (N = 24) achieved pregnancy without the hysteroscopic biopsy-
induced endometrium injury (p < 0.05).
Conclusions: Our proof-of-concept study demonstrates that a site-specific hysteroscopic endometrium injury
performed during the ongoing in vitro fertilization (IVF) cycle, instead of injuries received during prior cycles,
significantly improves clinical outcomes in patients with repeated implantation failure.
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Background
In assisted reproductive technology, procedures for cul-
turing and transferring embryos have been continually
improved over the last two decades. Yet the clinical
pregnancy rate has not substantially improved over the
last ten years (currently only 32.4~33.0% per IVF trans-
fer as reported by ESHRE in 2010)[1], and many
patients have suffered repeated implantation failure even
in the most successful in vitro fertilization (IVF) clinics.
Although no practical solutions for repeated implanta-
tion failure have emerged, an improved ability to control
the endometrial environment for implantation promises
to have a significant, positive impact on IVF outcomes.
Among the various potential causes of repeated
implantation failure, uterine factors (e.g., thin endome-
trium, poor endometrial receptivity, and immunological
incompatibility) have received the most attention in
recent years [2]. It has been shown that endometrial
receptivity could be modulated by a multitude of signal-
ing molecules, including prostaglandins [3], growth fac-
tors, cytokines, chemokines, integrins, leukemia
inhibitory factor [4,5], Wnt family ligands [6], and E-
cadherin [7]. Whereas dysregulation of some of these
factors could be associated with repeated implantation
failure, key molecular mechanisms that underlie the reg-
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Interestingly, earlier studies have shown that prior
incidences of hysteroscopic endometrium biopsy are
associated with increased rates of implantation, clinical
pregnancy, and live birth among women who experi-
enced repeated implantation failure but without obvious
endometrium defects, suggesting that a hysteroscopic
procedure in the nonconceptual cycle itself could be
beneficial for improving pregnancy in subsequent IVF
cycles [2,9-13]. This hypothesis has been supported–
directly or indirectly–in a number of clinical settings
[9-13]. Although earlier studies aiming to understand
the effect of hysteroscopic endometrium biopsy on
implantation have been methodologically diverse, a
common denominator appears to have been the pre-
sence of local injuries prior to an IVF cycle. Because
local inflammatory and angiogenesis reactions are indis-
pensable for a successful implantation [14], an endome-
trial biopsy-induced injury could produce just such a
local inflammatory and angiogenic environment between
the endometrium and the conceptus, which, in turn,
facilitates embryo implantation and subsequent preg-
nancy in earlier studies [9,15,16].
However, due to substantial variations in patient selec-
tion, timing, number and extent of endometrial injury
applied, and techniques in earlier studies [9,10,17-19],
the merits of endometrial biopsy injury on clinical out-
comes in IVF clinics remain controversial [2]. In the
present study, we reasoned that, if a local injury is the
key causal agent for improved pregnancy outcomes,
then a single site-specific mechanical injury performed
shortly before a scheduled embryo transfer should yield
a similar result. Herein, we demonstrate that a standard
IVF protocol in which a minimal intervention in the
form of a site-specific endometrial injury (which was
not intended for diagnostic or operative purposes) dur-
ing the controlled ovarian hyperstimulation cycle leads
to a dramatic improvement in the pregnancy rate of
patients with repeated implantation failure.
Methods
Subjects
The study was approved by the institutional ethics com-
mittee review board of Chang Gung Memorial Hospital
Linkou Medical Center. Institutional Review Board
approval was obtained in accordance with the Helsinki
Declaration of 1975 on human experimentation. All
patients gave written informed consent to participate in
the study. Repeated implantation failure was defined as
the failure to conceive following at least two cycles of
IVF and the transfer of good-quality embryos. Select
patients who have consent to receive the hysteroscopic
procedure during the ongoing hyperstimulation cycle
were recruited for the site-directed hysteroscopic biopsy
treatment.
Hyperstimulation protocol and hysteroscopic procedure
Ovulation induction was performed by the administra-
tion of recombinant FSH (175 - 225 IU/day, Puregon,
N.V. Organon, The Netherlands) starting on day 2 of
the menstrual cycle. GnRH antagonist (0.125 mg/day,
Cetrorelix, Serono) was given beginning on day 5 of
rFSH injection, or when the leading follicle reached 10
mm, to the day of hCG administration.
The single site-specific hysteroscopic biopsy procedure
was performed using an electronic gynecological exami-
nation chair with the patient in a semirecumbent posi-
tion. No premedication or local anesthetic was used. A
Cuscoe’s speculum was inserted into the vagina in order
to visualize the cervix. Panoramic hysteroscopy was per-
formed using a 4.9 mm diameter flexible hysteroscope
(HYF-1T, Olympus Corporation, Shinjuku-ku, Tokyo,
Japan). A 5% Dextrose distending medium was propelled
by an electronic pump (Endomat, Kar Storz, Tuttlingen,
Germany) with an intrauterine pressure of approxi-
mately 45 mm Hg. A claw forceps (A4033, Olympus
Corporation, Shinjuku-ku, Tokyo, Japan) was introduced
through a 2.2 mm working channel, and used to gener-
ate a local injury on the posterior endometrium at mid-
line 10-15 mm from the fundus on D4 to D7 of the
stimulation cycle. The depth and width of the injured
site was 2 × 2 mm (i.e., a bite of the claw forceps). No
antibiotic or hemostatic drug was administered after the
procedure.
Once the leading follicle reached a size of at least 16
mm, 10, 000 IU of urinary hCG (Pregnyl 5, 000 IU, N.V.
Organon, The Netherlands) was administrated to trigger
ovulation. Ovum retrieval was performed 34 hr after the
hCG injection. Embryos were transferred transvaginally
on day 3 of culture or at the blastocyst stage, and the
tip of the catheter (Labotect Gmbh, Germany) was
placed at 10-15 mm from the uterine fundus with a
transfer volume of ~10 μl. The luteal phase was sup-
ported with progesterone (8% vaginal-gel, Crinone, Pro-
chieve). Clinical pregnancy was defined as visualization
of fetal cardiac activity on transvaginal ultrasound
examination.
Statistical analysis
Results were presented as mean ± SD and analyzed by
the Student’s paired t-test. A p value < 0.05 was consid-
ered statistically significant.
Results
During a 6-month period (March to October 2010), a
total of 30 patients with predominant diagnoses of tubal
factor (n = 7) or unexplained infertility (n = 23) were
recruited. From this group, 6 patients who had consent
to the procedure were subsequently treated with the
hysteroscopic biopsy protocol. Two of these patients
Huang et al. Reproductive Biology and Endocrinology 2011, 9:140
http://www.rbej.com/content/9/1/140
Page 2 of 6
had predominant diagnoses of tubal factor, and four had
unexplained infertility. These participants ranged in age
from 31 to 39 (mean = 34.0 ± 3.0), and the mean num-
ber of previous IVF cycle attempts for these cases was
2.8 ± 0.8. In these patients, there was no difference in
total dose of gonadotropin used, E2 levels on the day of
hCG administration, fertilization rate, and the number
of embryos transferred between previous unsuccessful
cycles and the cycle during which the hysteroscopic
biopsy-induced endometrium injury was performed (Fig-
ure 1, Table 1). In these patients, there was a trend
toward having a thicker endometrium in cycles under-
going endometrial biopsy; however, the difference did
not reach statistical significance (10.3 ± 2.0 mm vs. 8.7
± 2.2 mm, p = 0.26). In addition, we observed a thin
hypoechogenic endometrium on the day of endometrial
biopsy in all patients, and a triple-line multi-layered pat-
tern of endometrium was found on the day of hCG
administration. The hysteroscopic technique obviously
did not alter this expected transition in endometrial lin-
ing pattern.
Of importance, we found that the implantation rate of
patients in the treatment group was 56% (Tables 1 and
2), and a total of six pregnancies (100%)–four singleton,
one twin, and one triplet–were recorded after the hys-
teroscopic intervention cycles. By contrast, 24 patients
who had similar clinical characteristics but did not
receive the hysteroscopic intervention recorded only a
21% rate of implantation per transferred embryo and a
46% (11/24) clinical pregnancy rate (Table 2). Consis-
tently, the control group has a higher early abortion rate
(27% (3/11)) as compared to the treatment group (0%
(0/6)) at the 12th week of gestation (Additional file 1,
Supplemental Table S1).
Discussion
Although major advances have been made in improving
oocyte and embryo development in IVF clinics in the
last two decades, hurdles remain in achieving high
embryo implantation rates for many patients. For both
patients and clinicians, one of the most discouraging
issues in IVF treatments is the recognition of repeated
implantation failure after transfers of good-quality
embryos because it has been generally accepted that
pregnancy and implantation rates are significantly lower
for patients who undergo their second or third cycles of
treatment as compared to those undergoing their first
cycle of IVF [20].
Whereas causes of defective implantation in patients
with repeated implantation failure could be multi-factor-
ial or even originate from embryonic defects (e.g.,
genetic abnormalities and embryonic aneuploidy), earlier
observations noted that patients who had received hys-
teroscopic biopsies prior to subsequent IVF cycle for
various reasons had a higher pregnancy rate [2]. This
observation has led to the hypothesis that endometrium
injury might improve pregnancy in patients with
repeated implantation failure as a result of subsequent
inflammatory responses and changes in cytokine pro-
duction in the endometrium [9-11,21]. Although a num-
ber of subsequent studies have reported significant
correlations between incidence of hysteroscopic biopsy
and improved pregnancy; however, it has not been
directly defined what injury per se is the causal agent
for the observed improvement because almost all earlier
studies have applied blind and nonspecific injuries dur-
ing cycles prior to the final controlled ovarian hypersti-
mulation cycle. In addition to variations in the type and
extent of injuries received by patients, it is conceivable
that the effect of endometrium injuries given long before
the subsequent embryo-transferring cycle could be les-
sened by subsequent menses.
Because the exact injury and timing required to effec-
tively improve implantation is not clear, the value of
hysteroscopic injury for improving pregnancy in patients
with repeated implantation failure remains to be estab-
lished. To specifically investigate whether a local injury
itself is sufficient to improve implantation, we applied a
hysteroscopic biopsy at a specific site of the endome-
trium (posterior wall 10-15 mm from the fundus) during
a specific time window (D4 to D7) of the ongoing sti-
mulation cycle–instead of relying on nonspecific injuries
from prior cycles. This design has effectively eliminated
Figure 1 Image of an operation during which an injury in the
endometrium was generated using a flexible
hysterofibrescope. The injured site is indicated by an arrow.
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many confounding effects associated with the extent and
duration of nonspecific injuries administered in earlier
studies. In addition, by incorporating the intervention
process into the traditional IVF procedure, this study
has allowed us to compare differences not only between
treatment groups but also between the biopsy cycle and
earlier failed cycles in these patients. Furthermore, we
chose to perform the biopsy at a specific location of the
endometrium because it has been recently shown that
the deposition of embryos at 10 to 20 mm from the
uterine fundus allows patients receiving IVF to reach a
higher pregnancy rate [22]. Consistent with our hypoth-
esis, the results demonstrated that a site-specific
hysteroscopic biopsy-induced endometrium injury dur-
ing the follicular phase of an ongoing IVF cycle can sig-
nificantly improve implantation and pregnancy rates.
This result is important because this hysteroscopic
intervention protocol could become a standard proce-
dure for treating repeated implantation failure. Nonethe-
less, it is important to note that our proof-of-concept
study was performed with a small group of patients, and
that there are differences in the total units of gonadotro-
pin administered and the total number of previously
transferred embryos between the two study groups
(Table 2). Future studies with larger populations of
patients are needed to validate current findings.
Table 1 Clinical characteristics of patients who received a site-specific endometrium injury during the final IVF cycle
Characteristics The IVF cycle with a biopsy Previous failed cyclesa p valueb
Length of stimulation (day) 8.7 ± 1.0 9.9 ± 1.3 0.11
Total units of gonadotropin administered 1570 ± 377 1893 ± 270 0.10
Endometrium thickness on the day of hCG administration (mm) 10.3 ± 2.0 8.7 ± 2.2 0.26
E2 levels on the day of hCG administration (pg/mL) 1623 ± 550 1825 ± 879 0.64
Number of oocytes retrieved 11.3 ± 2.9 7.1 ± 3.1 0.03
Fertilization rate (%) 59 ± 29 49 ± 18 0.52
Number of embryos transferred 2.7 ± 1.2 2.3 ± 1.1 0.91
Implantation rate (sac number/transferred embryo number) 56% 0
Pregnancy rate (clinical pregnancy/per ET) 100% 0
aMeasurements are the mean of parameters recorded in previous failed cycles
bStudent’s t -test of comparisons between the ongoing and prior IVF cycles
Table 2 Comparison of clinical characteristics and treatment outcomes of patients with or without a site-specific
hysteroscopic biopsy-induced endometrium injury during the final IVF cycle
Characteristics Patients with a site-specific endometrium injury
(N = 6)




Mean age (yr) 34 ± 3.0 35 ± 4.1 0.58
Weight (kg) 53.4 ± 3.0 54.3 ± 7.4 0.80
FSH (mIU/mL) 6.7 ± 2.3 6.9 ± 2.8 0.86
LH (mIU/mL) 4.2 ± 1.9 4.3 ± 2.1 0.89
Duration of Infertility (yr) 5.7 ± 2.8 6.4 ± 2.9 0.58
Total number of previously transferred embryos 5.0 ± 2.2 7.8 ± 3.0 0.06
Total number of previously IVF/ICSI cycles 2.8 ± 0.8 2.8 ± 0.9 0.88
Length of stimulation (day) 8.7 ± 1.0 9.2 ± 1.1 0.24
Total units of gonadotropin administrated (IU) 1570 ± 377 2206 ± 513 0.01
Endometrium thickness on the day of hCG administration
(mm)
10.3 ± 2.0 9.8 ± 2.1 0.62
E2 levels on the day of hCG administration (pg/mL) 1623 ± 550 1822 ± 1078 0.67
Number of oocytes retrieved 11.3 ± 2.9 13.5 ± 7.4 0.50
Number of fertilizations 7.2 ± 4.6 6.3 ± 4.0 0.66
Fertilization rate (%) 59 ± 29 50 ± 22 0.45
Number of all embryos 3.8 ± 2.3 4.8 ± 2.0 0.32
Number of embryos transferred 2.7 ± 1.2 3.0 ± 0.5 0.29
Implantation rate (sac number/transferred embryo) 56% 21% 0.01
Pregnancy rate (clinical pregnancy/per ET) 100% 46% 0.04
Early abortion rate (abortion before 12 wks/total
pregnancy)
0% (0/6) 27% (3/11)
aStudent’s t -test of comparisons between control and treatment groups
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For a successful pregnancy in placental mammals, two
major physiological events have to occur: (a) building a
receptive uterine endometrium for embryo implantation,
and (b) protecting the semiallotypic fetus from attacks
by the maternal immune system. Although the exact
mechanism by which the local injury improves preg-
nancy remains to be investigated, our study has
strengthened the hypothesis that a mechanical injury
may enhance uterine receptivity. By provoking the
immune system with an injury, the immune response
and inflammatory reactions associated with wound heal-
ing in the endometrium may, in turn, increase the endo-
metrial receptivity to the semiallotypic embryo [23].
Alternatively, the local injury could generate a focus for
the accumulation of uterine dendritic cells and accom-
panying increases in innate immune molecules [24], or
provide an enhanced angiogenic environment enriched
with cytokines and growth factors known to be essential
for normal trophoblast invasion.
Conclusions
As a whole, our pilot study has provided direct evidence
to support the hypothesis that a local injury performed
during an ongoing IVF cycle is beneficial for implanta-
tion in patients with repeated implantation failure, and a
discrete procedure for further testing the hypothesis
that a site-specific mechanical injury could improve
pregnancy outcomes. In addition, we envision that the
establishment of this discrete procedure could provide a
platform for systematic investigations of molecular
mechanisms underlying endometrium injury-mediated
improvement in implantation and the role of various
inflammatory factors in regulating endometrium recep-
tivity in humans.
Additional material
Additional file 1: Supplemental Table S1. Clinical outcomes of patients
with a clinical pregnancy.
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